⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16807902 | 1.00 | — | — | |
| SCHEMBL13413381 | 1.00 | — | — | |
| SCHEMBL8265625 | 1.00 | — | — | |
| SCHEMBL18726946 | 1.00 | — | — | |
| SCHEMBL2560705 | 1.00 | — | — | |
| SCHEMBL9273942 | 0.97 | TSHR (0.50) | — | |
| SCHEMBL11037568 | 0.82 | TSHR (0.47) | — | |
| SCHEMBL14038079 | 0.82 | TSHR (0.47) | — | |
| SCHEMBL29623845 | 0.82 | TSHR (0.47) | — | |
| SCHEMBL29624067 | 0.82 | TSHR (0.47) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170151153-A1 | POWERFUL HAIR TREATMENT AGENT WITH ANTI-WASHOUT EFFECT | HENKEL AG & CO. KGAA (DE) | 2017-06-01 | — | — | US | disclosed |
| WO-2016128996-A2 | AN IMPROVED PROCESS FOR PREPARATION OF TICAGRELOR AND INTERMEDIATES THEREOF | STRIDES SHASUN LIMITED (IN) | 2016-08-18 | — | — | WO | disclosed |
| US-8546404-B2 | Compounds that are ERK inhibitors | MERCK SHARP & DOHME (US) | 2013-10-01 | — | — | US | disclosed |
| EP-1794126-B1 | CRYSTALLINE FORM OF N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE HEMI-TARTRATE | ACADIA PHARM INC (US) | 2013-03-20 | — | — | EP | disclosed |
| US-8288531-B2 | Preparation process | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2012-10-16 | — | — | US | disclosed |
| WO-2011110954-A1 | HIGHLY PURE VARENICLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF SUBSTANTIALLY FREE OF METHYLVARENICLINE IMPURITY | ACTAVIS GROUP PTC EHF (IS) | 2011-09-15 | — | — | WO | disclosed |
| WO-2010023561-A9 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2011-08-04 | — | — | WO | disclosed |
| US-20110087021-A1 | NOVEL PREPARATION PROCESS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2011-04-14 | — | — | US | disclosed |
| WO-2010151476-A2 | CRYSTALLINE FORMS OF (3R, 3AS, 6AR) - HEXAHYDROFURO [2,3-B] FURAN-3-YL (1S,2R) - (1-{4-[ (DIETHOXYPHOSPHORYL) METHOXY] PHENY1}-3-HYDROXY-4- [4-METHOXY-N- (2-METHYLPROPYL) BENZENESUL - FONAMIDO] BUTAN-2-YL) CARBAMATE | GILEAD SCIENCES, INC. (US) | 2010-12-29 | — | — | WO | disclosed |
| WO-2010143070-A2 | AMORPHOUS VARENICLINE TARTRATE CO-PRECIPITATES | ACTAVIS GROUP PTC EHF (IS) | 2010-12-16 | — | — | WO | disclosed |
| WO-2009143347-A9 | VARENICLINE TOSYLATE, AN INTERMEDIATE IN THE PREPARATION PROCESS OF VARENICLINE L-TARTRATE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2010-07-29 | — | — | WO | disclosed |
| EP-1735302-B1 | 4-AMINO-PIPERIDINE DERIVATIVES AS MONOAMINE UPTAKE INHIBITORS | LILLY CO ELI (US) | 2010-06-16 | — | — | EP | disclosed |
| WO-2010023561-A1 | PROCESS FOR PREPARING VARENICLINE, VARENICLINE INTERMEDIATES, AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF | ACTAVIS GROUP PTC EHF (IS) | 2010-03-04 | — | — | WO | disclosed |
| WO-2010005643-A1 | PROCESSES FOR PURIFYING VARENICLINE L-TARTRATE SALT AND PREPARING CRYSTALLINE FORMS OF VARENICLINE L-TARTRATE SALT | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009143347-A2 | VARENICLINE TOSYLATE, AN INTERMEDIATE IN THE PREPARATION PROCESS OF VARENICLINE L-TARTRATE | TEVA PHARMACEUTICAL INDUSTRIES LTD. (IL) | 2009-11-26 | — | — | WO | disclosed |
| US-7556844-B2 | Radiation curable photochromic inks | XEROX CORPORATION (US) | 2009-07-07 | — | — | US | disclosed |
| US-20090118284-A1 | Novel compounds that are ERK inhibitors | MERCK SHARP & DOHME LLC | 2009-05-07 | — | — | US | disclosed |
| US-7459014-B2 | Radiation curable inks containing curable gelator additives | XEROX CORPORATION (US) | 2008-12-02 | — | — | US | disclosed |
| US-20070211110-A1 | RADIATION CURABLE PHOTOCHROMIC INKS | XEROX CORPORATION (US) | 2007-09-13 | — | — | US | disclosed |
| WO-2007088073-A1 | ZOPICLONE RESOLUTION USING L-TARTARIC ACID | SYNTHON B.V. (NL) | 2007-08-09 | — | — | WO | disclosed |